ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2026
Mapping nationally adopted targets for antimicrobial consumption and stewardship indicators in the human health domain, 25 European Union/European Economic Area countries, 2025.
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUNDEstablishing quantifiable targets for antimicrobial consumption (AMC) and stewardship activities can provide a structured framework for monitoring and evaluating progress in efforts to curb antimicrobial resistance (AMR).AIMWe aimed to map the presence and characteristics of national AMC-related targets in the human health domain across European Union (EU)/European Economic Area (EEA) countries, thereby creating an inventory to inform current and future target-setting initiatives.METHODSWe performed a survey within the European Surveillance of Antimicrobial Consumption Network (ESAC-Net) to identify national AMC-related targets in force for 2025 or later.RESULTSBased on responses received from 25 EU/EEA countries, we identified a total of 67 nationally adopted AMC-related targets, active for 2025 or beyond, from 16 countries. Targets for population-level AMC indicators were the most frequently reported (73%), followed by patient-level AMC indicators (18%) and structural stewardship indicators (9%). The influential role of the 2023 EU Council Recommendation on AMR and its recommendations for national targets was particularly evident in our findings.CONCLUSIONThis inventory provides examples of national targets and related implementation and monitoring frameworks used across a range of settings and resource levels. Our findings highlight the importance of robust and sustainable surveillance infrastructure and reporting systems to support the development, implementation, monitoring and evaluation of AMC-related national targets. Such systems are also needed to enable targets that capture prescribing practices and antimicrobial stewardship activities, beyond overall consumption volume metrics alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.